Nutritional management for Alzheimer’s disease in all stages: mild, moderate, and severe
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2316-7874
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nutritional management for Alzheimer’s disease in all stages: mild, moderate, and severe ; volume:42 ; number:1 ; day:10 ; month:1 ; year:2017 ; pages:1-6 ; date:12.2017
Nutrire ; 42, Heft 1 (10.1.2017), 1-6, 12.2017
- Keyword
-
Ernährung
Ernährungsberatung
Diätetik
- Creator
-
Pivi, Glaucia Akiko Kamikado
- Contributor
-
Vieira, Neusa Maria de Andrade
da Ponte, Jaqueline Botelho
de Moraes, Débora Santos Coca
Bertolucci, Paulo Henrique Ferreira
SpringerLink (Online service)
- DOI
-
10.1186/s41110-016-0025-7
- URN
-
urn:nbn:de:1111-201701311205
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pivi, Glaucia Akiko Kamikado
- Vieira, Neusa Maria de Andrade
- da Ponte, Jaqueline Botelho
- de Moraes, Débora Santos Coca
- Bertolucci, Paulo Henrique Ferreira
- SpringerLink (Online service)
Other Objects (12)
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Language impairment in the moderate stage of dementia due to Alzheimer's disease
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Zulassungserweiterung - Memantine auch bei moderater Alzheimer-Demenz
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Oral Health Status and Nutritional Habits as Predictors for Developing Alzheimer’s Disease
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Language impairment in the moderate stage of dementia due to Alzheimer's disease
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Zulassungserweiterung - Memantine auch bei moderater Alzheimer-Demenz
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Oral Health Status and Nutritional Habits as Predictors for Developing Alzheimer’s Disease
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Language impairment in the moderate stage of dementia due to Alzheimer's disease
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Zulassungserweiterung - Memantine auch bei moderater Alzheimer-Demenz
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Oral Health Status and Nutritional Habits as Predictors for Developing Alzheimer’s Disease
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?